Marks-Konczalik and colleagues reported that IL-15 inhibited activation-induced cell death that results from continuous IL-2 stimulation (67)and unlike IL-2, IL-15 does not induce activation and proliferation of Tregs (68), which results in peripheral tolerance and potentially leads to a more robust anti-tumor response. This evidence concerns the gene IL2 and neoplasm.